Whit Mayo, an analyst from Leerink Partners, reiterated the Hold rating on Agilon Health (AGL – Research Report). The associated price target is $2.50. Whit Mayo has given his Hold rating due to a ...

BTIG analyst David Larsen has maintained their neutral stance on AGL stock, giving a Hold rating today. David Larsen’s rating is based ...

Fintel reports that on November 11, 2024, JMP Securities downgraded their outlook for agilon health (NYSE:AGL) from Market ...

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wolfe Research Healthcare ...

In the last three months, 3 analysts have published ratings on Agilon Health AGL, offering a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings ...

agilon health, inc. (NYSE:AGL – Get Free Report) has been given an average recommendation of “Hold” by the twenty-one ratings firms that are currently covering the company, Marketbeat.com ...

AUSTIN, Texas, November 05, 2024--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will ...